Related Experiment Videos
Heart transplant rejection treated with plasmapheresis
J Partanen1, M S Nieminen, L Krogerus
1First Department of Medicine, University Central Hospital, Helsinki, Finland.
Summary
This case study highlights a heart transplant patient whose vascular rejection did not respond to steroids. Plasmapheresis effectively treated the rejection and vasculitis, suggesting its potential use in similar transplant cases.
Area of Science:
- Cardiology
- Transplantation Immunology
- Nephrology
Background:
- Orthotopic heart transplantation is a life-saving procedure for end-stage heart failure.
- Acute rejection remains a significant challenge, impacting graft survival.
- Vascular rejection, a component of mixed rejection, can be difficult to manage.
Observation:
- A 30-year-old male heart transplant recipient presented with mixed-type rejection.
- The vascular component of rejection was refractory to standard steroid therapy.
- Clinical signs and biopsy-proven vasculitis persisted despite immunosuppression.
Findings:
- Plasmapheresis was initiated as a salvage therapy.
- The patient experienced resolution of clinical rejection symptoms.
- Follow-up biopsy revealed significant improvement in microscopic vasculitic changes.
Implications:
- This case suggests plasmapheresis may be a valuable therapeutic option for acute vascular rejection post-heart transplantation.
- It highlights the need for alternative treatment strategies when standard immunosuppression fails.
- Further research into plasmapheresis for refractory transplant rejection is warranted.